EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis

Alejandro Bruna-Mejias, Vicente Baeza, Javiera Gamboa, Belen Baez Flores, Jessica San Martin iD, Constanza Astorga, Javiera Leyton, Pablo Nova-Baeza iD, Mathias Orellana-Donoso, Alejandra Suazo-Santibañez, Alvaro Becerra-Farfán iD, Gustavo Oyanedel-Amaro und 1 weitere

Pharmaceuticals · 03.09.2024 · 17 (9) · 1165

DOI: 10.3390/ph17091165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 03.09.2024. Verfasst von Alejandro Bruna-Mejias und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias y Geografía, Facultad de Ciencias Naturales y Exactas, Universidad de Playa Ancha, Valparaíso 2360072, Chile. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain (NP) is a heterogeneous group of conditions characterized by the experience of a number of sensory disturbances including pain, burning sensations, paroxysms of stabbing pain, dysesthesias, allodynia, and hyperalgesia. The above-mentioned sensations may occur in a specific dermatome area or other delimited region of the body. The objective of this review was to analyze the evidence for ketamine in multifactorial neuropathic pain. The research group systematically searched the databases MEDLINE (via PubMed), EMBASE, SCOPUS, the Cochrane Central Register of Controlled Trials, the Cumulative Index to Nursing and Allied Health Literature (Cinahl), and the Web of Science. The findings of this review show that different forms of low doses of ketamine (LDK) do not present statistically significant changes for any of the scales included. In this study, the total symptom score [standardized mean difference (SMD) = −3.59, confidence interval (CI) = −4.16 to −3.02, and p < 0.00001], neuropathy impairment score (SMD = −1.42, CI = −3.68 to 0.84, and p = 0.22), and neuropathy symptom checklist (SMD = −0.09, CI = −0.15 to −0.02, and p = 0.01) were taken into account. For finality compared to the use of a placebo, the findings suggest that LDK does not exhibit significant differences in terms of pain reduction and functionality. Moreover, no specific dosages are identified to support the use of LDK in the reduction in NP.

Schlagwörter

Stichwörter der Autor:innen

ketamineneuropathic painpharmacologypolyneuropathy

Autor:innen und Institutionen

  • Departamento de Ciencias y Geografía, Facultad de Ciencias Naturales y Exactas, Universidad de Playa Ancha, Valparaíso 2360072, Chile.
  • Departamento de Morfología, Facultad de Medicina, Universidad Andres Bello, Santiago 8420524, Chile.
  • Faculty of Medicine and Science, Universidad San Sebastián, Santiago 8420524, Chile.
  • Escuela de Medicina, Universidad Finis Terrae, Santiago 7501015, Chile.
  • Faculty of Health and Social Sciences, Universidad de las Américas, Santiago 8370040, Chile.
  • Escuela de Fonoaudiología & Departamento de Ciencias Química y Biológicas, Facultad de Ciencias de la Salud, Universidad Bernardo O'Higgins, Santiago 8320000, Chile.

ORCID-Profile: Jessica San Martin, Pablo Nova-Baeza, Alvaro Becerra-Farfán

Zitieren

APA

Bruna-Mejias, A., Baeza, V., Gamboa, J., Baez Flores, B., San Martin, J., Astorga, C., Leyton, J., Nova-Baeza, P., Orellana-Donoso, M., Suazo-Santibañez, A., Becerra-Farfán, A., Oyanedel-Amaro, G., & Valenzuela-Fuenzalida, J. J. (2024). Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis. Pharmaceuticals, 17(9), 1165. https://doi.org/10.3390/ph17091165

Vancouver

Bruna-Mejias A, Baeza V, Gamboa J, Baez Flores B, San Martin J, Astorga C, et al. Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2024;17(9):1165. doi:10.3390/ph17091165

BibTeX
@article{BrunaMejias2024,
  author = {Bruna-Mejias, Alejandro and Baeza, Vicente and Gamboa, Javiera and Baez Flores, Belen and San Martin, Jessica and Astorga, Constanza and Leyton, Javiera and Nova-Baeza, Pablo and Orellana-Donoso, Mathias and Suazo-Santibañez, Alejandra and Becerra-Farfán, Alvaro and Oyanedel-Amaro, Gustavo and Valenzuela-Fuenzalida, Juan Jose},
  title = {Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {9},
  pages = {1165},
  doi = {10.3390/ph17091165}
}
Kostenlos starten →